Cross-Disciplinary Cardiovascular and Psychiatric Recommendations: A Systematic Review of Clinical Guidelines.

Int J Psychiatry MedJun 12, 2025 (epub)
Clinical ResearchCardiologyPsychiatry

Marina Delli Colli, Kyle T Greenway, Michael Goldfarb

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined how American and European cardiology and psychiatric society guidelines published from 2013–2023 address the relationship between serious mental illness and cardiovascular disease. It included 26 guidelines: 13 cardiovascular and 13 psychiatric. Psychiatric considerations appeared in 5 cardiovascular guidelines (38%), whereas 10 psychiatric guidelines (77%) included cardiovascular recommendations. Cross-disciplinary content was more common in European than U.S. guidelines in both fields, indicating uneven integration of cardiovascular and psychiatric guidance.

Key findings

  • Psychiatric considerations appeared in 5 cardiovascular guidelines (38%); only 13% of American versus 80% of European cardiovascular guidelines included psychiatric content.
  • Ten psychiatric guidelines (77%) included cardiovascular recommendations; cardiovascular content appeared in 40% of U.S. and 100% of European psychiatric guidelines.
  • Psychiatric guidelines addressed cardiovascular screening (n = 16), pharmacological considerations (n = 8), and risk factor control (n = 7).

Why it matters

People with serious mental illness experience disproportionately high cardiovascular risk and disease, yet the review found that guidance across the two disciplines is not consistently integrated. This gap may leave clinicians without coordinated recommendations spanning mental illness, cardiovascular risk assessment, medication considerations, and risk-factor management. The findings support attention to cross-disciplinary guidance while not establishing whether particular recommendations improve outcomes.

What to keep in mind

The review assessed guideline content, not the implementation of recommendations or their effects on cardiovascular outcomes.

Source

Published in Int J Psychiatry Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.